Daisuke Hokka

Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report

Kazuhiro Minami, Naoe Jimbo, Yugo Tanaka et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2019 · 34 citations

Tumoral Pathology, Malignant Disease, Malignant Mesothelioma +7

Sirt1 is a tumor promoter in lung adenocarcinoma

Xue Chen, Daisuke Hokka, Yoshimasa Maniwa et al. · Oncology Letters · 2014 · 31 citations · Full text

Psf3 is a prognostic biomarker in lung adenocarcinoma

Daisuke Hokka, Yoshimasa Maniwa, Shinya Tane et al. · Lung Cancer · 2012 · 27 citations

Prognostic Biomarkers, Medicine, Lung Adenocarcinoma +7

Significant role of Psf3 expression in non‐small‐cell lung cancer

Shinya Tane, Yasuhiro Sakai, Daisuke Hokka et al. · Cancer Science · 2015 · 24 citations · Full text

Clinical significance of the ‘not otherwise specified’ subtype in candidates for resectable non-small cell lung cancer

Shinya Tane, Wataru Nishio, Hiroyuki Ogawa et al. · Oncology Letters · 2014 · 20 citations · Full text